Defining a standard set of patient-centred outcomes for lung cancer

European Respiratory Journal

Volumn 48, Issue 3, 2016, Pages 852-860

  Mak, Kimberley S ^a,b,c   Van Bommel, Annelotte C M ^a,d   Stowell, Caleb ^a   Abrahm, Janet L ^e   Baker, Matthew ^f   Baldotto, Clarissa S ^g   Baldwin, David R ^h   Borthwick, Diana ⁱ   Carbone, David P ^j   Chen, Aileen B ^k   Fox, Jesme ^l   Haswell, Tom ^m   Koczywas, Marianna ⁿ   Kozower, Benjamin D ^o   Mehran, Reza J ^p   Schramel, Franz M ^q   Senan, Suresh ^r   Stirling, Robert G ^s   Van Meerbeeck, Jan P ^t   Wouters, Michel W J M ^u,v   Peake, Michael D ^w,x   more..

^a International Consortium for Health Outcomes Measurement   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d Dutch Institute for Clinical Auditing   (Netherlands)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f Patient Representative   (United Kingdom)

^g Clínicas Oncológicas Integradas ^*  (Brazil)

^h NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

ⁱ Edinburgh Cancer Research Centre   (United Kingdom)

^j OHIO STATE UNIVERSITY   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l The Roy Castle Lung Cancer Foundation   (United Kingdom)

^m Patient Representative   (United Kingdom)

ⁿ CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^o UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^p UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^q ST ANTONIUS HOSPITAL   (Netherlands)

^r VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^s MONASH UNIVERSITY   (Australia)

^t ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^u NETHERLANDS CANCER INSTITUTE   (Netherlands)

^v Dutch Institute for Clinical Auditing   (Netherlands)

^w UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^x PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DELPHI STUDY; ETHNICITY; FORCED EXPIRATORY VOLUME; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH STATUS; HUMAN; LUNG CANCER; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SMALL CELL LUNG CANCER; SOCIAL STATUS; TERMINAL CARE; TUMOR VOLUME; CONSENSUS; COUGHING; DYSPNEA; FATIGUE; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; LUNG TUMOR; ONCOLOGY; ORGANIZATION AND MANAGEMENT; PAIN MEASUREMENT; PSYCHOLOGY; PULMONOLOGY; REGISTER; STANDARDS; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CONSENSUS; COUGH; DYSPNEA; FATIGUE; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; LUNG NEOPLASMS; MEDICAL ONCOLOGY; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PATIENT-CENTERED CARE; PULMONARY MEDICINE; QUALITY OF LIFE; REGISTRIES; TREATMENT OUTCOME;

EID: 84986224335     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02049-2015     Document Type: Article

References (40)

1. International Agency for Research on Cancer, World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx Date last accessed: October 23, 2015.
2. World Health Organization. Cancer. Fact Sheet No 297. www.who.int/mediacentre/factsheets/fs297/en/Date last accessed: October 23, 2015. Date last updated: February, 2015.
3. Chen Z, Fillmore CM, Hammerman PS, et al. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 2014; 14: 535-546.
4. Krohn A, Ahrens T, Yalcin A, et al. Tumor cell heterogeneity in small cell lung cancer (SCLC): phenotypical and functional differences associated with epithelial-mesenchymal transition (EMT) and DNA methylation changes. PLoS One 2014; 9: e100249.
5. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15: 23-34.
6. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
7. United States Department of Health and Human Services. Better, Smarter, Healthier: In Historic Announcement, HHS Sets Clear Goals and Timeline for Shifting Medicare Reimbursements from Volume to Value. www.hhs.gov/news/press/2015pres/01/20150126a.html Date last accessed: October 22, 2015. Date last updated: January 26, 2014.
8. Ashley L, Jones H, Thomas J, et al. Integrating patient reported outcomes with clinical cancer registry data: a feasibility study of the electronic Patient-Reported Outcomes From Cancer Survivors (ePOCS) system. J Med Internet Res 2013; 15: e230.
9. Weeks JC, Catalano PJ, Cronin A, et al. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med 2012; 367: 1616-1625.
10. Freidlin B, Korn EL, Hunsberger S, et al. Proposal for the use of progression-free survival in unblinded randomized trials. J Clin Oncol 2007; 25: 2122-2126.
11. Dubey S, Brown RL, Esmond SL, et al. Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer. J Support Oncol 2005; 3: 149-154.
12. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
13. US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7.pdf Date last accessed: October 23, 2015. Date last updated: June 14, 2010.
14. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980; 65: 25-32.
15. Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998; 317: 771-775.
16. Sloan JA, Zhao X, Novotny PJ, et al. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol 2012; 30: 1498-1504.
17. Gridelli C, Perrone F, Nelli F, et al. Quality of life in lung cancer patients. Ann Oncol 2001; 12: Suppl. 3, S21-S25.
18. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
19. Bergman B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 1994; 30A: 635-642.
20. Maringwa JT, Quinten C, King M, et al. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer 2011; 19: 1753-1760.
21. Ediebah DE, Coens C, Zikos E, et al. Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. Br J Cancer 2014; 110: 2427-2433.
22. Groenvold M, Petersen MA, Aaronson NK, et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 2006; 42: 55-64.
23. Wahl I, Löwe B, Bjorner JB, et al. Standardization of depression measurement: a common metric was developed for 11 self-report depression measures. J Clin Epidemiol 2014; 67: 73-86.
24. Wenemark M, Persson A, Noorlind Brage H, et al. Applying motivation theory to achieve increased response rates, respondent satisfaction and data quality. J Off Stat 2011; 27: 393-414.
25. Petersen MA, Groenvold M, Aaronson NK, et al. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions-general approach and initial results for physical functioning. Eur J Cancer 2010; 46: 1352-1358.
26. Vinas F, Ben Hassen I, Jabot L, et al. Delays for diagnosis and treatment of lung cancers: a systematic review. Clin Respir J 2016; 10: 267-271.
27. Everitt S, Herschtal A, Callahan J, et al. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer. Cancer 2010; 116: 5030-5037.
28. Phelby D, Martinez C, Roumagnac M, et al. Recommendations for Coding Incidence Date. Ispra, European Network of Cancer Registries, 1995.
29. Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004; 22: 315-321.
30. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
31. Gerritsen RT, Hofhuis JG, Koopmans M, et al. Perception by family members and ICU staff of the quality of dying and death in the ICU: a prospective multicenter study in The Netherlands. Chest 2013; 143: 357-363.
32. Forrest LF, Adams J, Wareham H, et al. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med 2013; 10: e1001376.
33. Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA 2005; 294: 2879-2888.
34. United Nations Educational, Scientific and Cultural Organization. International Standard Classification of Education: ISCED 2011. www.uis.unesco.org/Education/Documents/isced-2011-en.pdf Date last accessed: October 23, 2015. Date last updated: 2012.
35. Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003; 49: 156-163.
36. Olomu AB, Corser WD, Stommel M, et al. Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly? BMC Health Serv Res 2012; 12: 398.
37. Movember Foundation. Prostate Cancer Outcomes Info Sheet. https://cdn.movember.com/uploads/files/Funded Programs/Movember-Foundation-Prostate-Cancer-Outcomes-Info-Sheet.pdf Date last accessed: April 19, 2016.
38. Berenson RA, Kaye DR. Grading a physician's value-the misapplication of performance measurement. N Engl J Med 2013; 369: 2079-2081.
39. Berge EM, Doebele RC. Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor. Semin Oncol 2014; 41: 110-125.
40. Jensen RE, Rothrock NE, DeWitt EM, et al. The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. Med Care 2015; 53: 153-159.